HEPA — Hepion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Hepion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	91.3	51.2	14.8	0.406	1.83
Prepaid Expenses
Total Current Assets	97.5	56.5	17.5	1.61	3.07
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.456	0.132	0.242	0	—
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	104	60.2	18.1	1.61	3.07
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.21	7.89	5.29	3.14	0.299
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	10.6	10.4	10.8	3.48	0.402
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	93	49.9	7.28	-1.86	2.67
Total Liabilities & Shareholders' Equity	104	60.2	18.1	1.61	3.07
Total Common Shares Outstanding
Total Preferred Shares Outstanding